title: Does the type of progestin influence the production of clotting factors?
authors.affiliation: Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA; Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA. Electronic address: fstanczyk@att.net.
authors.forename: Frank Z
authors.initials: FZ
authors.lastname: Stanczyk
authors.affiliation: Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.
authors.forename: Brett W
authors.initials: BW
authors.lastname: Mathews
authors.affiliation: Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA; Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.
authors.forename: Victoria K
authors.initials: VK
authors.lastname: Cortessis
mesh_terms: D001779:Blood Coagulation Factors; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D006487:Hemostasis; D006801:Humans; D011372:Progestins / Q000009:adverse effects* / Q000494:pharmacology; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D001779:Blood Coagulation Factors; D003277:Contraceptives, Oral, Combined; D004967:Estrogens; D011372:Progestins